Shares of Life Science REIT plc (LON:LABS - Get Free Report) shot up 1.8% during mid-day trading on Friday . The company traded as high as GBX 40.70 ($0.53) and last traded at GBX 40.50 ($0.53). 316,170 shares were traded during trading, a decline of 70% from the average session volume of 1,053,393 shares. The stock had previously closed at GBX 39.80 ($0.52).
Analyst Upgrades and Downgrades
Several research firms have recently commented on LABS. Shore Capital restated a "buy" rating on shares of Life Science REIT in a report on Thursday, September 26th. Berenberg Bank restated a "buy" rating and set a GBX 57 ($0.74) price target on shares of Life Science REIT in a research note on Thursday, October 3rd. Finally, Jefferies Financial Group lowered their price objective on shares of Life Science REIT from GBX 45 ($0.58) to GBX 36 ($0.47) and set a "hold" rating on the stock in a report on Friday, August 30th.
Read Our Latest Stock Analysis on Life Science REIT
Life Science REIT Price Performance
The stock has a fifty day moving average of GBX 35.85 and a 200 day moving average of GBX 35.80. The firm has a market capitalization of £141.75 million, a P/E ratio of -675.00 and a beta of 0.08.
Life Science REIT Dividend Announcement
The business also recently announced a dividend, which will be paid on Thursday, October 31st. Stockholders of record on Thursday, October 3rd will be given a dividend of GBX 1 ($0.01) per share. This represents a dividend yield of 3.11%. The ex-dividend date is Thursday, October 3rd. Life Science REIT's dividend payout ratio is currently -3,333.33%.
About Life Science REIT
(
Get Free Report)
Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.
Further Reading
Before you consider Life Science REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Life Science REIT wasn't on the list.
While Life Science REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
